IMMUNOGENETIC STUDIES OF BCL-2 PROTEIN EXPRESSION IN ACUTE HUMAN LEUKEMIA
Shereen Hassan Badawy El Wakeel;
Abstract
Leukemia usually acute lymphoblastic leukemia is the most common infant malignancy (30%), followed by the central nervous system cancer and neuroblastoma.
On the other hand, BCL-2 was first identified as oncogen by its ability to inhibit lymphocyte cell d
On the other hand, BCL-2 was first identified as oncogen by its ability to inhibit lymphocyte cell d
Other data
| Title | IMMUNOGENETIC STUDIES OF BCL-2 PROTEIN EXPRESSION IN ACUTE HUMAN LEUKEMIA | Other Titles | دراسات وراثية مناعية لتعبير بروتين BCL-2 على سرطان الدم الحاد في الإنسان | Authors | Shereen Hassan Badawy El Wakeel | Keywords | IMMUNOGENETIC STUDIES OF BCL-2 PROTEIN EXPRESSION IN ACUTE HUMAN LEUKEMIA | Issue Date | 2009 | Description | Leukemia usually acute lymphoblastic leukemia is the most common infant malignancy (30%), followed by the central nervous system cancer and neuroblastoma. On the other hand, BCL-2 was first identified as oncogen by its ability to inhibit lymphocyte cell d |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.